CRBU
Price
$1.94
Change
+$0.06 (+3.19%)
Updated
Nov 28 closing price
Capitalization
181.33M
105 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$31.96
Change
+$0.24 (+0.76%)
Updated
Nov 28 closing price
Capitalization
3.05B
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs VRDN

Header iconCRBU vs VRDN Comparison
Open Charts CRBU vs VRDNBanner chart's image
Caribou Biosciences
Price$1.94
Change+$0.06 (+3.19%)
Volume$407.37K
Capitalization181.33M
Viridian Therapeutics
Price$31.96
Change+$0.24 (+0.76%)
Volume$651.61K
Capitalization3.05B
CRBU vs VRDN Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. VRDN commentary
Dec 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and VRDN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 01, 2025
Stock price -- (CRBU: $1.94 vs. VRDN: $31.96)
Brand notoriety: CRBU and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 15% vs. VRDN: 42%
Market capitalization -- CRBU: $181.33M vs. VRDN: $3.05B
CRBU [@Biotechnology] is valued at $181.33M. VRDN’s [@Biotechnology] market capitalization is $3.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRBU and VRDN are a good buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а +10.86% price change this week, while VRDN (@Biotechnology) price change was +5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($3.05B) has a higher market cap than CRBU($181M). VRDN YTD gains are higher at: 66.719 vs. CRBU (22.013). CRBU has higher annual earnings (EBITDA): -150.76M vs. VRDN (-340.62M). VRDN has more cash in the bank: 563M vs. CRBU (184M). VRDN has less debt than CRBU: VRDN (21.3M) vs CRBU (25.9M). CRBU has higher revenues than VRDN: CRBU (9.12M) vs VRDN (305K).
CRBUVRDNCRBU / VRDN
Capitalization181M3.05B6%
EBITDA-150.76M-340.62M44%
Gain YTD22.01366.71933%
P/E RatioN/AN/A-
Revenue9.12M305K2,990%
Total Cash184M563M33%
Total Debt25.9M21.3M122%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUVRDN
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 28 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETAGX61.550.50
+0.82%
Eventide Gilead A
NBHEX15.660.11
+0.71%
Neuberger Berman Equity Income E
SBHAX21.290.12
+0.57%
Segall Bryant & Hamill All Cap Instl
JFRNX68.030.26
+0.38%
Janus Henderson Forty N
WASMX24.78-0.01
-0.04%
Boston Trust Walden SMID Cap

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+0.76%
NUVL - VRDN
56%
Loosely correlated
+0.27%
XNCR - VRDN
52%
Loosely correlated
-0.35%
SYRE - VRDN
52%
Loosely correlated
+0.84%
CLDX - VRDN
51%
Loosely correlated
+0.86%
CRNX - VRDN
50%
Loosely correlated
-1.02%
More